Pharma's Almanac TV
PA TV
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Press Releases
2257 Articles Available
1
95
Can't find what you're looking for? Try our
advanced search
.
Obesity
Kintai Therapeutics Advances Anti-Obesity Agent After Demonstrating Sustained Weight Loss
PR-M01-20-NI-039
Partnership
The Health Plan Serving Over 200,000 Covered Lives Selects NantHealth’s NaviNet® Open to Drive Provider Engagement Strategy
PR-M01-20-NI-040
API Manufacturing
Piramal Pharma Solutions Invests $25 Million CAD to Expand its Aurora, Canada Facility with a State-of-the-Art API Manufacturing Wing
PR-M01-20-NI-038
2020-21 Blavatnik Fellowship at Yale: Applications Now Accepted
PR-M01-20-NI-037
Clinical Trials
Roche’s Risdiplam Meets Primary Endpoint in Pivotal FIREFISH Trial
PR-M01-20-NI-036
Sustainability
AstraZeneca’s ‘Ambition Zero Carbon’ Strategy to Eliminate Emissions by 2025 and be Carbon Negative Across the Entire Value Chain by 2030
PR-M01-20-NI-035
Cell and Gene Therapy
The Center for Breakthrough Medicines to Build a Cell and Gene Therapy CDMO in King of Prussia, PA
PR-M01-20-NI-035
Investment
Governor Cooper Announces Over 460 Jobs in Durham as Eli Lilly and Company Selects North Carolina for Major Pharmaceutical Plant
PR-M01-20-NI-034
Leadership
Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of Directors
PR-M01-20-NI-033
M&A
Lilly Announces Agreement to Acquire Dermira
PR-M01-20-NI-032
Oncology
Dozens of Non-Oncology Drugs Can Kill Cancer Cells
PR-M01-20-NI-031
Collaboration
NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration For Ulcerative Colitis
PR-M01-20-NI-030
Artificial Intelligence
Insilico Enters into Artificial Intelligence Collaboration with Pfizer
PR-M01-20-NI-029
Drug Pricing
Lilly Expands Insulin Affordability Options
PR-M01-20-NI-028
Partnership
Civica Rx Partners with Thermo Fisher Scientific to Develop and Manufacture Drugs with a History of Drug Shortages
PR-M01-20-NI-027
Cancer Breakthrough
Progress Report on Cancer Breakthroughs 2020 Project Presented by Dr. Soon-Shiong at J.P. Morgan Healthcare Conference
PR-M01-20-NI-026
M&A
Wuxi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
PR-M01-20-NI-025
M&A
Bosch Packaging Technology is now Syntegon
PR-M01-20-NI-023
Market Research
Parenteral Drugs Market to Exhibit 6% CAGR, on Back of Surging Demand for Self-administered Drugs
PR-M01-20-NI-023
Market Prediction
Popularity of Generic Drugs Poised to Overshadow Atherosclerosis Drugs Market Growth
PR-M01-20-NI-022
Generics
Seqens North America Identifies Trends Affecting the Generic Drugs Sector in 2020
PR-M01-20-NI-021
Cancer Treatment
NantKwest and ImmunityBio Announce Complete Response in Metastatic Pancreatic Cancer Patient
PR-M01-20-NI-020
M&A
ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.
PR-M01-20-NI-019
Collaboration
Evotec and Bristol-Myers Squibb Expand iPSC Collaboration
PR-M01-20-NI-018
1
95
»
